top of page

TestAVec and Vidiia accelerating DNA damage testing platform

TestAVec and Vidiia are working together to accelerate DiNARep to commercial testing. DiNARep identifies if patients are able to repair DNA breaks, determining thier eligibility for gene therpay and tollerance for other treatments that cuase DNA damage, including chemotherapy. TestAVec and Vidiia have partnered together to accelerate this service into a streamlines and high throughput platform. Vidiia works to develop technologies that tackle disease challenges accross the world enabling people to take control of thier health and wellbieng. At TestAVec, we are excited to continue this project together and develop a high throughput pipelines for DiNARep.



Comments


bottom of page